BrainGym – Bob Dennis – ICES vs. Pemf – Micropulse – AMT01.

4 in 5 people ELIMINATE chronic pain with this PEMF | Dr. Bob Dennis Interview

PEMF Magnetic Therapy Device AMT- 01, comprado en 71 dólares más el adapador de V220 a V110.

The low-frequency sinusoidal magnetic field:

  • has analgesic and anti-inflammatory effect;
  • improves microcirculatory processes and local blood circulation, contributing to the resolution of inflammatory and traumatic edema and the restoration of damaged tissues;
  • has a beneficial effect on the central nervous system, improving general condition, sleeping and reducing irritability;
  • strengthens the human immune system.
  • The AMT-01 generates on its small working surface an inhomogeneous alternating magnetic field with a frequency of 50 Hz and a given magnetic induction.

The therapeutic Indications:  

1. gastritis
2. pneumonic fever
3. bronchial asthma
4. bronchitis
5. bronchitis  in children
6. tracheitis
7. tracheobronchitis
8. genyantritis
9. frontal sinusitis
10. rhinitis
11. duodenal ulcer
12. cholecystitis
13. hepatitis
14. cervicalgia
15. cervicalgia
16. cervicobrachialgia
17. cervical radiculitis
18. thoracalgia
19. thoracal radiculitis
20. lumbago
21. lumbodynia
22. lumboischialgia
23. lumbosacral radiculitis
24. coccygodynia
25. humeroscapular
26. ulnar
27. radiocarpal
28. carpal polyarthritis
29. hip joint arthrosis
30. gonarthrosis
31. ambilateral gonarthrosis
32. prominent heel
33. achillodynia
34. maim of abarthrosis and soft parts
35. traumatism
36. adnexitis
37. ambilateral adnexitis
38. cystitis, cystalgia
39. idiopathic hypertensia
40. thrombophlebitis
41. cerebral atherosclerosis
42. concussion of the brain

ICES model M1 PEMF Protocols: Myths, facts, and opinions

ICES – Products

ICES, $1600

The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder

refrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6 weeks (20–30 sessions) is US Food and Drug Administration (FDA) approved for treating Major Depressive Disorder in adults who have not responded to prior antidepressant medications. In 2011, leading TMS clinical providers and researchers created the Clinical TMS Society (cTMSs) (, Greenwich, CT, USA), incorporated in 2013.

PEMF: Clearing up the confusion (part 1) – 12 things you need to know

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.